Revisiting and re-engineering the classical zinc finger peptide: consensus peptide-1 (CP-1)

2016 ◽  
Vol 12 (4) ◽  
pp. 1183-1193 ◽  
Author(s):  
Angelique N. Besold ◽  
Leland R. Widger ◽  
Frances Namuswe ◽  
Jamie L. Michalek ◽  
Sarah L. J. Michel ◽  
...  

Zinc plays key structural and catalytic roles in biology.

1991 ◽  
Vol 113 (12) ◽  
pp. 4518-4523 ◽  
Author(s):  
Beth Allyn Krizek ◽  
Barbara T. Amann ◽  
Valda J. Kilfoil ◽  
Denise L. Merkle ◽  
Jeremy M. Berg

1997 ◽  
Vol 41 (3) ◽  
pp. 687-692 ◽  
Author(s):  
A K Judd ◽  
A Sanchez ◽  
D J Bucher ◽  
J H Huffman ◽  
K Bailey ◽  
...  

Matrix protein (M1) is a major structural protein of influenza virus, and it inhibits its own polymerase. A 19-amino-acid peptide, corresponding to a zinc finger region of the M1 sequence of influenza virus strain A/PR/8/34 (H1N1), centered around amino acids 148 to 166, was synthesized. This peptide, designated peptide 6, represents a zinc finger which includes a 7-amino-acid loop or finger and a 4-amino-acid tail at the carboxyl terminus, in addition to the 8 amino acids involved in the coordination of Zn. Three experiments were run to evaluate the activity of peptide 6 on infections induced in mice by influenza A/PR/8/34 and A/Victoria/3/75 (H3N2) viruses. Intranasal (i.n.) treatment of the H1N1 virus infection with 30 or 60 mg/kg of body weight/day, three times daily for 5 days, beginning 4 h pre-or 8 h post-virus exposure, was effective in preventing death, reducing the arterial oxygen decline, and inhibiting lung consolidation. Virus titers in the lungs determined on day 5 were reduced by up to 1.5 log10 in treated groups, but considerable variation in the titers of the recovered virus was seen. The H3N2 virus infection was treated i.n. with 30, 60, or 120 mg of peptide 6/kg/day by using the above-mentioned delayed initiation treatment schedule, and similar protection was seen, although lung virus titers were not reduced in the day-5 assay. Peptide 6 was well tolerated at doses up to 60 mg/kg/day. This zinc finger peptide may provide a new class of antivirals effective against influenza virus.


2007 ◽  
Vol 119 (36) ◽  
pp. 7010-7014 ◽  
Author(s):  
Olalla Vázquez ◽  
M. Eugenio Vázquez ◽  
Juan B. Blanco ◽  
Luis Castedo ◽  
José L. Mascareñas

1998 ◽  
Vol 273 (28) ◽  
pp. 17425-17432 ◽  
Author(s):  
Guritno Roesijadi ◽  
Ralf Bogumil ◽  
Milan Vasák ◽  
Jeremias H. R. Kägi

2003 ◽  
Vol 278 (22) ◽  
pp. 19947-19955 ◽  
Author(s):  
Perry J. Blackshear ◽  
Wi S. Lai ◽  
Elizabeth A. Kennington ◽  
Gary Brewer ◽  
Gerald M. Wilson ◽  
...  

2011 ◽  
Vol 47 (1) ◽  
pp. 412-414 ◽  
Author(s):  
Yana Berezovskaya ◽  
Craig T. Armstrong ◽  
Aimee L. Boyle ◽  
Massimiliano Porrini ◽  
Derek N. Woolfson ◽  
...  

2014 ◽  
Vol 53 (12) ◽  
pp. 6309-6320 ◽  
Author(s):  
Ka Lam Chan ◽  
Inna Bakman ◽  
Amy R. Marts ◽  
Yuksel Batir ◽  
Terry L. Dowd ◽  
...  

2013 ◽  
Vol 49 (62) ◽  
pp. 6986 ◽  
Author(s):  
John B. Mangrum ◽  
Ibrahim Zgani ◽  
Samantha D. Tsotsoros ◽  
Yun Qu ◽  
Nicholas P. Farrell

Sign in / Sign up

Export Citation Format

Share Document